EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pseudovirus Nanoparticles Displaying the Receptor-Binding Glycoprotein of Marburg Virus as Potential Vaccine Candidates

Ming Xia iD, Frank S Vago, Ming Tan iD

Pathogens · 2026

DOI: 10.3390/pathogens15101087 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens, 2026. Verfasst von Ming Xia und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA. Hauptthemen laut MEDLINE: Marburgvirus, Nanoparticles, Viral Vaccines, Viral Envelope Proteins. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The lack of a licensed vaccine against the deadly Marburg virus (MARV) calls for the development of a novel and effective vaccine strategy.

Methods

We report here our development of three pseudovirus nanoparticles (PVNPs), each displaying a MARV-neutralizing glycoprotein (GP) segment of different lengths, as MARV vaccine candidates. These PVNPs, designated S-GP278, S-GP377, and S-GP486, were generated using our proprietary norovirus shell nanoparticle (SNP) platform. The PVNPs were evaluated for their production, self-assembly, morphology, structural properties, and immunogenicity.

Results

Our data demonstrated that the three recombinant S-GP proteins, S-GP278, S-GP377, and S-GP486, can be produced at low cost using an E. coli expression system. The purified recombinant S-GP proteins self-assembled into PVNPs with high efficacy. Structural modeling of the S-GP1 PVNPs highlighted their key architectural features, consisting of an icosahedral inner shell and multiple trimeric GP structures displayed on the surface. Immunization of mice with the S-GP PVNPs elicited high titers of GP-specific antibodies, including IgG and IgA.

Conclusions

Collectively, these data support the notion that the S-GP PVNPs may serve as potential MARV vaccine candidates worthy of further development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MarburgvirusNanoparticlesViral VaccinesViral Envelope ProteinsMarburg Virus DiseaseGlycoproteinsAnimalsMiceAntibodies, ViralFemaleProtein Subunit VaccinesNanovaccinesAntibodies, NeutralizingRecombinant Proteins

Stichwörter der Autor:innen

Marburg virusMarburg virus vaccinenorovirus S nanoparticlepseudovirus nanoparticlereceptor-binding glycoprotein

Substanzen

Viral VaccinesAntibodies, ViralViral Envelope ProteinsProtein Subunit VaccinesGlycoproteinsNanovaccinesAntibodies, NeutralizingRecombinant Proteins

Autor:innen und Institutionen

  • Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
  • Department of Biological Sciences, Purdue University, West Lafayette, IN 47907, USA.
  • Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA.

ORCID-Profile: Ming Xia, Ming Tan

Förderung

  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases

Zitieren

APA

Xia, M., Vago, F. S., & Tan, M. (2026). Pseudovirus Nanoparticles Displaying the Receptor-Binding Glycoprotein of Marburg Virus as Potential Vaccine Candidates. Pathogens. https://doi.org/10.3390/pathogens15101087

Vancouver

Xia M, Vago FS, Tan M. Pseudovirus Nanoparticles Displaying the Receptor-Binding Glycoprotein of Marburg Virus as Potential Vaccine Candidates. Pathogens. 2026. doi:10.3390/pathogens15101087

BibTeX
@article{Xia2026,
  author = {Xia, Ming and Vago, Frank S and Tan, Ming},
  title = {Pseudovirus Nanoparticles Displaying the Receptor-Binding Glycoprotein of Marburg Virus as Potential Vaccine Candidates},
  journal = {Pathogens},
  year = {2026},
  doi = {10.3390/pathogens15101087}
}
Kostenlos starten →